U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 1116

1.
Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial
Christina Johnson, Jinbo Chen, Mary P. McGowan, Eric Tricou, Mary Card, Amy R. Pettit, Tamar Klaiman, Daniel J. Rader, Kevin G. Volpp, Rinad S. Beidas
Implement Sci. 2024; 19: 30. Published online 2024 Apr 9. doi: 10.1186/s13012-024-01355-x
PMCID:
PMC11003060
ArticlePDF–1.1M
2.
Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia
Hayato Tada, Nobuko Kojima, Yasuaki Takeji, Atsushi Nohara, Masa-aki Kawashiri, Masayuki Takamura
Am J Prev Cardiol. 2024 Jun; 18: 100660. Published online 2024 Mar 24. doi: 10.1016/j.ajpc.2024.100660
PMCID:
PMC10999807
ArticlePDF–1.8M
3.
Profiling of differentially expressed MicroRNAs in familial hypercholesterolemia via direct hybridization
Erika Cione, Maryam Mahjoubin-Tehran, Tiziana Bacchetti, Maciej Banach, Gianna Ferretti, Amirhossein Sahebkar
Noncoding RNA Res. 2024 Sep; 9(3): 796–810. Published online 2024 Mar 8. doi: 10.1016/j.ncrna.2024.02.017
PMCID:
PMC10999490
ArticlePDF–12M
4.
Retracted: A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia
BioMed Research International
Biomed Res Int. 2024; 2024: 9865038. Published online 2024 Mar 20. doi: 10.1155/2024/9865038
Retracts:
Biomed Res Int. 2021; 2021: 8032978.
PMCID:
PMC10977109
RetractionPDF–514K
5.
Early Atherosclerosis in Familial Hypercholesterolemia Patients: Significance of Vascular Markers for Risk Stratification
Urte Aliosaitiene, Zaneta Petrulioniene, Egidija Rinkuniene, Antanas Mainelis, Jurate Barysiene, Urte Smailyte, Vaida Sileikiene, Aleksandras Laucevicius
J Cardiovasc Dev Dis. 2024 Mar; 11(3): 91. Published online 2024 Mar 13. doi: 10.3390/jcdd11030091
PMCID:
PMC10971247
ArticlePDF–1.1M
6.
The Health History of First-Degree Relatives’ Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia
Tomoharu Tokutomi, Akiko Yoshida, Akimune Fukushima, Kayono Yamamoto, Yasushi Ishigaki, Hiroshi Kawame, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Mika Sakurai-Yageta, Akira Uruno, Kichiya Suzuki, Kozo Tanno, Hideki Ohmomo, Atsushi Shimizu, Masayuki Yamamoto, Makoto Sasaki
Genes (Basel) 2024 Mar; 15(3): 384. Published online 2024 Mar 21. doi: 10.3390/genes15030384
PMCID:
PMC10970353
ArticlePDF–515K
7.
Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia
Hayato Tada, Masa-aki Kawashiri, Atsushi Nohara, Tomoko Sekiya, Atsushi Watanabe, Masayuki Takamura
Genes (Basel) 2024 Mar; 15(3): 297. Published online 2024 Feb 26. doi: 10.3390/genes15030297
PMCID:
PMC10970256
ArticlePDF–1.8M
8.
Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor
Burabha Pussadhamma, Chaiyasith Wongvipaporn, Atthakorn Wutthimanop, Manit Nuinoon, Sureerut Porntadavity, Nutjaree Jeenduang
Sci Rep. 2024; 14: 6785. Published online 2024 Mar 21. doi: 10.1038/s41598-024-57069-z
PMCID:
PMC10957951
ArticlePDF–2.3M
9.
LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
Kaihan Wang, Tingting Hu, Mengmeng Tai, Yan Shen, Haocheng Chai, Shaoyi Lin, Xiaomin Chen
Lipids Health Dis. 2024; 23: 85. Published online 2024 Mar 21. doi: 10.1186/s12944-024-02068-2
PMCID:
PMC10956282
ArticlePDF–1.8M
10.
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
PLoS One. 2024; 19(3): e0297231. Published online 2024 Mar 20. doi: 10.1371/journal.pone.0297231
PMCID:
PMC10954175
ArticlePDF–2.1M
11.
Failure of lipid control by PCSK9 inhibitors in compound heterozygous familial hypercholesterolemia complicated with premature myocardial infarction: A case report
Ziyue Zhang, Rongpei Yang, Jun Zhu, XiaoLi Yang, Hao Luo, Hongyong Wang, Xiaoli Luo
Clin Case Rep. 2024 Mar; 12(3): e8498. Published online 2024 Mar 14. doi: 10.1002/ccr3.8498
PMCID:
PMC10939999
ArticlePDF–855K
12.
Development and utility of a clinical research informatics application for participant recruitment and workflow management for a return of results pilot trial in familial hypercholesterolemia in the Million Veteran Program
Charles A Brunette, Thomas Yi, Morgan E Danowski, Mark Cardellino, Alicia Harrison, Themistocles L Assimes, Joshua W Knowles, Kurt D Christensen, Amy C Sturm, Yan V Sun, Qin Hui, Saiju Pyarajan, Yunling Shi, Stacey B Whitbourne, J Michael Gaziano, Sumitra Muralidhar, Jason L Vassy
JAMIA Open. 2024 Apr; 7(1): ooae020. Published online 2024 Mar 8. doi: 10.1093/jamiaopen/ooae020
PMCID:
PMC10923213
ArticlePDF–1.1M
13.
Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study
Huijuan Kou, Hongtao Wang, Peng Liu, Xin Wang, Wenjing Zhu, Wei Jiang, Xiaojun Hu, Jie Deng
BMC Cardiovasc Disord. 2024; 24: 144. Published online 2024 Mar 5. doi: 10.1186/s12872-024-03803-4
PMCID:
PMC10913252
ArticlePDF–1.7M
14.
A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE‐1 insertion in LDLR
Yongjun Song, Reham Abdel Haleem Abo Elwafa, Omneya Magdy Omar, Go Hun Seo, Hane Lee
Mol Genet Genomic Med. 2024 Mar; 12(3): e2410. Published online 2024 Mar 4. doi: 10.1002/mgg3.2410
PMCID:
PMC10910215
ArticlePDF–1.2M
15.
Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
Maria Elena Capra, Giacomo Biasucci, Giuseppe Banderali, Andrea Vania, Cristina Pederiva
Children (Basel) 2024 Feb; 11(2): 250. Published online 2024 Feb 15. doi: 10.3390/children11020250
PMCID:
PMC10887291
ArticlePDF–548K
16.
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia
Giosiana Bosco, Francesco Di Giacomo Barbagallo, Maurizio Di Marco, Nicoletta Miano, Sabrina Scilletta, Salvatore Spampinato, Alessio Vitale, Federica Di Bella, Maria Montalbano, Stefania Di Mauro, Agnese Filippello, Alessandra Scamporrino, Agostino Milluzzo, Antonino Di Pino, Lucia Frittitta, Francesco Purrello, Salvatore Piro, Roberto Scicali
Front Endocrinol (Lausanne) 2024; 15: 1346152. Published online 2024 Feb 8. doi: 10.3389/fendo.2024.1346152
PMCID:
PMC10885347
ArticlePDF–640K
17.
Spatial lipidomics of coronary atherosclerotic plaque development in a familial hypercholesterolemia swine model
Nuria Slijkhuis, Francesca Razzi, Suze-Anne Korteland, Bram Heijs, Kim van Gaalen, Dirk J. Duncker, Antonius F.W. van der Steen, Volkert van Steijn, Heleen M.M. van Beusekom, Gijs van Soest
J Lipid Res. 2024 Feb; 65(2): 100504. Published online 2024 Jan 19. doi: 10.1016/j.jlr.2024.100504
PMCID:
PMC10879031
ArticlePDF–3.3M
18.
Phenotypic homozygous familial hypercholesterolemia successfully treated with proprotein convertase subtilisin/kexin type 9 inhibitors
Ryosuke Tani, Keiji Matsunaga, Yuta Toda, Tomoko Inoue, Hai Ying Fu, Tetsuo Minamino
Clin Case Rep. 2024 Feb; 12(2): e8537. Published online 2024 Feb 19. doi: 10.1002/ccr3.8537
PMCID:
PMC10876917
ArticlePDF–2.0M
19.
Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy
Piotr Fularski, Joanna Hajdys, Gabriela Majchrowicz, Magdalena Stabrawa, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
Int J Mol Sci. 2024 Feb; 25(3): 1637. Published online 2024 Jan 29. doi: 10.3390/ijms25031637
PMCID:
PMC10855128
ArticlePDF–774K
20.
Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial
Raul D. Santos, Albert Wiegman, Sonia Caprio, Bertrand Cariou, Maurizio Averna, Yann Poulouin, Michel Scemama, Garen Manvelian, Genevieve Garon, Stephen Daniels
JAMA Pediatr. 2024 Mar; 178(3): 283–293. Published online 2024 Feb 5. doi: 10.1001/jamapediatrics.2023.6477
PMCID:
PMC10845038
Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center